5 UK Dividend Stocks To Buy

Page 5 of 5

1. AstraZeneca PLC (NASDAQ:AZN)

Dividend Yield as of March 29: 2.18%

Number of Hedge Fund Holders: 42

AstraZeneca PLC (NASDAQ:AZN) was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. The company develops medicine and vaccines for cardiovascular, renal, respiratory, immunology, and metabolism diseases, among others. AstraZeneca PLC (NASDAQ:AZN)’s fourth quarter revenue of $12 billion exceeded estimates by $950.20 million. 

On February 10, AstraZeneca PLC (NASDAQ:AZN) declared a second interim dividend of $1.97 per share, which was paid on March 28. The stock yields 2.18% as of March 29. 

Stifel analyst Eric Le Berrigaud initiated coverage of AstraZeneca PLC (NASDAQ:AZN) on February 28 with a Buy rating and a 12,300 GBp price target. According to the analyst, AstraZeneca PLC (NASDAQ:AZN) will remain the fastest-growing pharma company over the next five years, and he does not see the stock “receiving the deserved valuation for this”. 

As per the Q4 database of Insider Monkey, 42 hedge funds were bullish on AstraZeneca PLC (NASDAQ:AZN), with collective stakes amounting to $3.8 billion. Avidity Partners Management owns a significant position in the company, with 2.8 million shares worth $167 million. 

You can also take a look at 10 Most Anticipated IPOs of 2022 and Top 10 Blue Chip Stocks to Buy in 2022

Page 5 of 5